| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.26 | 2e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.25 | 3e-06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.17 | 0.0008 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.16 | 0.002 |